327 related articles for article (PubMed ID: 17222314)
41. Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women?
Wolf LA; Terry PD; Potter JD; Bostick RM
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):676-83. PubMed ID: 17416757
[TBL] [Abstract][Full Text] [Related]
42. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
Triantafillidis JK; Nasioulas G; Kosmidis PA
Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
[TBL] [Abstract][Full Text] [Related]
43. [Clinical course of inflammatory bowel disease in patients transplanted for primary sclerosing cholangitis].
Villamil A; De Paula JA; Galdame O; Piccioni H; Ciardullo M; De Santibañes E; Gadano A
Acta Gastroenterol Latinoam; 2008 Dec; 38(4):252-9. PubMed ID: 19157380
[TBL] [Abstract][Full Text] [Related]
44. Prevalence and risk of colorectal neoplasia in consumers of alcohol in a screening population.
Anderson JC; Alpern Z; Sethi G; Messina CR; Martin C; Hubbard PM; Grimson R; Ells PF; Shaw RD
Am J Gastroenterol; 2005 Sep; 100(9):2049-55. PubMed ID: 16128951
[TBL] [Abstract][Full Text] [Related]
45. Plasma folate and risk of colorectal cancer in a nested case-control study: the Japan Public Health Center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Cancer Causes Control; 2008 Feb; 19(1):67-74. PubMed ID: 17943453
[TBL] [Abstract][Full Text] [Related]
46. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.
Gradel KO; Nielsen HL; Schønheyder HC; Ejlertsen T; Kristensen B; Nielsen H
Gastroenterology; 2009 Aug; 137(2):495-501. PubMed ID: 19361507
[TBL] [Abstract][Full Text] [Related]
47. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study.
Singh H; Demers AA; Nugent Z; Mahmud SM; Kliewer EV; Bernstein CN
Gastroenterology; 2009 Feb; 136(2):451-8. PubMed ID: 18996382
[TBL] [Abstract][Full Text] [Related]
48. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease.
García Rodríguez LA; Ruigómez A; Panés J
Gastroenterology; 2006 May; 130(6):1588-94. PubMed ID: 16697722
[TBL] [Abstract][Full Text] [Related]
49. Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.
Ryan BM; Russel MG; Langholz E; Stockbrugger RW
Am J Gastroenterol; 2003 Aug; 98(8):1682-7. PubMed ID: 12907319
[TBL] [Abstract][Full Text] [Related]
50. Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.
van Schaik FD; van Oijen MG; Smeets HM; van der Heijden GJ; Siersema PD; Oldenburg B
Gut; 2012 Feb; 61(2):235-40. PubMed ID: 21602529
[TBL] [Abstract][Full Text] [Related]
51. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003.
Hutfless SM; Weng X; Liu L; Allison J; Herrinton LJ
Gastroenterology; 2007 Dec; 133(6):1779-86. PubMed ID: 18054550
[TBL] [Abstract][Full Text] [Related]
52. 5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for 'best evidence'?
Giannini EG; Kane SV; Testa R; Savarino V
Dig Liver Dis; 2005 Oct; 37(10):723-31. PubMed ID: 16023905
[TBL] [Abstract][Full Text] [Related]
53. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.
Navaneethan U; Remzi FH; Nutter B; Fazio VW; Shen B
Am J Gastroenterol; 2009 Oct; 104(10):2467-75. PubMed ID: 19550410
[TBL] [Abstract][Full Text] [Related]
54. Risk factors for opportunistic infections in patients with inflammatory bowel disease.
Toruner M; Loftus EV; Harmsen WS; Zinsmeister AR; Orenstein R; Sandborn WJ; Colombel JF; Egan LJ
Gastroenterology; 2008 Apr; 134(4):929-36. PubMed ID: 18294633
[TBL] [Abstract][Full Text] [Related]
55. Smoking and colorectal cancer: different effects by type of cigarettes?
Lüchtenborg M; White KK; Wilkens L; Kolonel LN; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1341-7. PubMed ID: 17626999
[TBL] [Abstract][Full Text] [Related]
56. Dysplasia and cancer in inflammatory bowel disease.
Basseri RJ; Basseri B; Papadakis KA
Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):59-66. PubMed ID: 21309672
[TBL] [Abstract][Full Text] [Related]
57. Donation frequency, iron loss, and risk of cancer among blood donors.
Edgren G; Reilly M; Hjalgrim H; Tran TN; Rostgaard K; Adami J; Titlestad K; Shanwell A; Melbye M; Nyrén O
J Natl Cancer Inst; 2008 Apr; 100(8):572-9. PubMed ID: 18398098
[TBL] [Abstract][Full Text] [Related]
58. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies.
Jess T; Gamborg M; Matzen P; Munkholm P; Sørensen TI
Am J Gastroenterol; 2005 Dec; 100(12):2724-9. PubMed ID: 16393226
[TBL] [Abstract][Full Text] [Related]
59. High lifetime risk of cancer in primary sclerosing cholangitis.
Claessen MM; Vleggaar FP; Tytgat KM; Siersema PD; van Buuren HR
J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991
[TBL] [Abstract][Full Text] [Related]
60. Screening differences and risk of cervical cancer in inflammatory bowel disease.
Hutfless S; Fireman B; Kane S; Herrinton LJ
Aliment Pharmacol Ther; 2008 Sep; 28(5):598-605. PubMed ID: 18549465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
